Artificial Intelligence (AI) in Medical Diagnostics Market Segmentation:
Component Segment Analysis
The software segment is expected to show dominance in the artificial intelligence in medical diagnostics market with a share of 50.6% over the assessed period. Having better scalability and cost-efficiency compared to services and hardware, AI-as-a-Service (AIaaS) models have become the most preferred choice in this sector. According to the NLM report in April 2025, FDA has approved 434 AI driven medical devices in the U.S. with advanced AI/ML algorithms to enhance the accuracy and effectiveness in diagnosis. Moreover, the expedited surge in flexible and value-based diagnostic solutions is democratizing access to advanced medical services, which is propelling cash inflow in this sector.
End user Segment Analysis
Hospitals are leading the end user segment in the artificial intelligence in medical diagnostics market and are expected to hold a considerable share value by 2035. The segment is driven by the large patient volumes, extensive imaging infrastructure, and need for operational efficiency. They are the first adopters of integrated AI diagnostic solutions to decrease diagnostic mistakes, accelerate time-to-treatment, and control increasing healthcare expenditures. Government incentive programs and investments, including grants by the Centers for Disease Control and Prevention (CDC) for health IT modernization within clinical environments, enable hospitals to invest in these technologies, making them the largest market segment.
Technology Segment Analysis
Machine Learning, deep learning in particular, is the central technology that can enhance the capacity for learning from huge amounts of medical images and electronic health records to classify and predict. Its dominance is driven by public-private collaborations and grants from institutions such as the NIH financing research on the creation of strong ML algorithms to use for diagnosis to perpetuate technological development and verification. The NIH Common Fund's Bridge to Artificial Intelligence (Bridge2AI) program is a notable initiative, announced with an investment of around $130 million to accelerate the AI adoption in biomedical and behavioral research.
Our in-depth analysis of the AI in medical diagnostics market includes the following segments:
|
Segment |
Subsegment |
|
Component |
|
|
Diagnosis |
|
|
Technology |
|
|
Application |
|
|
End user |
|
